Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sertraline in the Treatment of Generalized Social Phobia With Comorbidity

NCT00182533 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.

NCT NCT00182533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00182533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sertraline in the Treatment of Generalized Social Phobia With Comorbidity
Lead sponsor
Hamilton Health Sciences Corporation
Phase
Phase 4
Overall status
Terminated
Start date
July 31, 2002
Completion date
January 31, 2018
Enrollment
170 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agoraphobia, anxiety disorders, major depressive disorder, obsessive-compulsive disorder, panic disorder, phobia, social